Publications

Latest Publications

2023.02.28
[Report from China] Chinese Courtroom TV Series – “Draw the Line”
2023.02.28
Response to the Risk of Misconduct in Business in China – Focusing on the Response to Signs of Misconduct
2023.02.28
Legal Affairs for Chinese Life Sciences and Healthcare No.16: Rejection of UCB Pharma S.A. and GlaxoSmithKline (Ireland) Limited in the Extraterritorial Off-Site Inspection
2023.02.28
A Commentary on the New Draft Amendment to the “Companies Law” of China – In Comparison with the First Draft Amendment
2023.02.28
Impact of the Enactment of the German Act, "Act on Corporate Due Diligence in Supply Chains," on Japanese Companies
2023.02.28
National Comparison Tables - Japan part
2023.02.27
China’s Life Science and Healthcare-No.3 Amendment of the Regulations on Cosmetics in China
2023.01.31
Attribution of the Right to Claim Mutual Aid Money Paid for an Event Covered by Mutual Aid that has Occurred after Renewal of the Contract Therefor
2023.01.31
Factoring and Insolvency Proceedings
2023.01.31
Signs of the Introduction of a Majority Vote-based Out-of-Court Liquidation Procedure – The Direction of New Legislation for Business Restructuring -
2023.01.20
[Report from China] Traveling to China Immediately after the Lifting of the “Zero-Covid” Policy
2023.01.20
Legal Affairs for Chinese Life Sciences and Healthcare No.15: System of the Person Responsible for the Production Safety (Safety Officer) of Food and Food-related Products in China
2023.01.20
Labor Issues after Reclassification of the Novel Coronavirus Infectious Disease as a “Category B Infectious Disease Managed under Category B Protocols”
2023.01.17
New Developments in the Public Campaigns for Shareholders Concerning Election and Dismissal of Officers - Considering the Disputes between Fujitec and Oasis
2023.01.13
[US Export Administration Regulations (EAR)] Expansion of the Extraterritorial Coverage of the US EAR (Direct Product Rule)
2023.01.13
[Business Restructuring] Outline of the Support Activities by the Small and Medium-Sized Enterprise Revitalization Support Council
2023.01.13
[Companies Act] Practical Response to the System for Providing Reference Documents for Shareholders Meetings in an Electrical Format
2023.01.13
[Companies Act] Implementation of Human Rights Due Diligence Based on the Government Guideline
2023.01.13
[Companies Act] Implementation of Human Rights Due Diligence Based on the Government Guideline
2022.12.28
[Report from China] Reversal of the Policies for the Novel Coronavirus Pandemic

Other publications

ページTOPへ